Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
Covington
Fuji
Harvard Business School
Farmers Insurance
Moodys
Colorcon
McKinsey

Generated: July 18, 2018

DrugPatentWatch Database Preview

Mephenytoin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for mephenytoin and what is the scope of mephenytoin patent protection?

Mephenytoin
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for mephenytoin
Medical Subject Heading (MeSH) Categories for mephenytoin
Synonyms for mephenytoin
(-)-5-Ethyl-3-methyl-5-phenylhydantoin
(?)-5-Ethyl-3-methyl-5-phenylhydantoin
(.+/-.)-5-Ethyl-3-methyl-5-phenylhydantoin
(+-)-5-Ethyl-3-methyl-5-phenylhydantoin
(+-)-Mephenytoin
(+/-)-5-Ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione
(+/-)-5-Ethyl-3-methyl-5-phenylhydantoin
(+/-)-Mephenytoin
2, 4-Imidazolidinedione, 5-ethyl-3-methyl-5-phenyl-
2, 5-ethyl-3-methyl-5-phenyl-
2,4-Imidazolidinedione, 5-ethyl-3-methyl-5-phenyl-
2,4-Imidazolidinedione, 5-ethyl-3-methyl-5-phenyl-, (+-)-
3-Ethylnirvanol
3-Methyl-5-ethyl-5-phenylh
3-Methyl-5-ethyl-5-phenylhydantoin
3-Methyl-5, 5-ethylphenylhydantoin
3-Methyl-5,5-ethylphenylhydantoin
3-Methyl-5,5-phenylethylhydantoin
4-ethyl-2-hydroxy-1-methyl-4-phenyl-4,5-dihydro-1H-imidazol-5-one
5 Ethyl 3 Methyl 5 Phenylhydantoin
5-Ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione
5-Ethyl-3-methyl-5-phenyl-2,4(3H,5H)-imidazoledione
5-Ethyl-3-methyl-5-phenyl-2,5H)-imidazoledione
5-ethyl-3-methyl-5-phenyl-imidazolidine-2,4-dione
5-Ethyl-3-methyl-5-phenylhydantoin
5-Ethyl-3-methyl-5-phenylimidazolidin-2,4-dione
5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione
5-Ethyl-5-fenyl-3-methylhydantoin
5-Ethyl-5-fenyl-3-methylhydantoin [Czech]
50-12-4
A1073/0050334
AB00052368
AB00052368_08
AB00052368-07
AC-15964
AC1L1HBP
AKOS015962176
API0003306
API0004188
BDBM50103593
BIM-0051837.0001
BPBio1_001338
BRD-A83937277-001-03-0
BRN 0017282
BSPBio_001216
CCG-213191
CHEBI:6757
CHEBI:91914
CHEMBL861
CS-4793
CTK8F2163
D00375
D07RGW
DB00532
DivK1c_000937
DL-Mephenytoin
DTXSID9023257
EINECS 200-012-8
Epiazin
Epilan
Fenantoin
Gerot-epilan
GL1129
GMHKMTDVRCWUDX-UHFFFAOYSA-N
GTPL7223
HE005373
HE299991
HE345903
HE384803
HMS1571M18
HMS2089J22
HMS2098M18
HMS2230E21
HMS3369F15
HMS502O19
HSDB 3581
HY-B1184
Hydantoin, 5-ethyl-3-methyl-5-phenyl-
IDI1_000937
Insulton
KBio1_000937
KBio2_001974
KBio2_004542
KBio2_007110
KBioGR_001508
KBioSS_001974
l-3-Methyl-5-ethyl-5-phenylhydantoin
l-Mephenytoin
LS-76188
LS-76189
MCULE-6021512202
Mefenetoin
Mefenitoina
Mefenitoina [INN-Spanish]
Mephenetoinum
mephentoin
Mephenytoin (USP/INN)
Mephenytoin [USAN:INN]
Mephenytoin [USAN:USP:INN:BAN]
Mephenytoin 1.0 mg/ml in Methanol
Mephenytoin, United States Pharmacopeia (USP) Reference Standard
MEPHENYTOIN; 5-ETHYL-3-METHYL-5-PHENYL-2,4-IMIDAZOLIDINEDIONE
Mephenytoine
Mephenytoine [INN-French]
Mephenytoinum
Mephenytoinum [INN-Latin]
Mesantoin
Mesantoin (TN)
Mesdontoin
Mesontoin
Methoin
Methyl hydantoin
Methyl Phenetoin
Methylphenetoin
Metydan
MFCD00022407
MLS002154157
MolPort-003-666-498
MU2276000
NCGC00165924-01
NCGC00165924-02
NINDS_000937
NSC 34652
NSC-34652
NSC34652
Oprea1_289074
Phenantoin
Phenetoin, Methyl
Phenylethylmethylhydantoin
Prestwick0_001108
Prestwick1_001108
Prestwick2_001108
Prestwick3_001108
Sacerno
SCHEMBL21766
Sedantional
Sedantoin
Sedantoinal
SMR001233457
SPBio_003088
Spectrum_001494
Spectrum4_001094
SR-05000001478
SR-05000001478-3
Triantoin
WLN: T5MVNV EHJ C1 E2 ER
ydantoin

US Patents and Regulatory Information for mephenytoin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis MESANTOIN mephenytoin TABLET;ORAL 006008-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
Chinese Patent Office
Julphar
Cipla
Johnson and Johnson
US Department of Justice
Accenture
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.